On March 25, 2019, Legacy Pharmaceutical Packaging issued a voluntary recall of 40 lots of Losartan potassium tablets due to NMBA. This is the fifth time in 2019 that Torrent Pharmaceuticals has expanded its voluntary recall … A recall of Torrent Pharmaceuticals Limited ’ s Losartan Potassium Tablets USP has been expanded to include 8 additional lots. We understand that this medicine is important to your health. Losartan is used to slow long-term kidney damage in people with type 2 diabetes who also have high blood pressure. Originally the company recalled 10 lots of the medication. The recalled bottles have “Sandoz,” the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets. Tests found trace amounts of … A total of 10 lots are now being recalled at the consumer level, including 2 recalled lots initially announced December 20, … Now, almost a year later, manufacturer Torrent Pharmaceuticals expands its voluntary recall for the 5th time. It is also used to lower the risk of stroke in certain people with heart disease. For the latest recall information as of September 25, 2019 check here: New Recall Expansion Announced for Certain Losartan Products. The recall involves both losartan potassium/hydrochlorothiazide tablets and losartan potassium tablets. Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. 1 Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity while testing the below finished product batches manufactured utilizing active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited … Losartan is considered a generic angiotensin II receptor blocker (ARB), and is primarily … The recall is expanded to include an additional 3 lots of Losartan Potassium Tablets USP and 2 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP. Legacy Pharmaceuticals also expanded its recall to include 1 additional lot of Losartan. Losartan works by allowing the blood vessels to open and be more relaxed. Last month, Torrent Pharmaceuticals Limited issued a voluntary recall of two lots of Losartan potassium tablets over similar concerns surrounding trace amounts of … A maker of losartan potassium is recalling this medicine because they may have small amounts of an ingredient which could cause cancer. The lots include losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets. Losartan and losartan potassium are the same medication and belong to a class of drugs called angiotensin II receptor blockers (ARBs). March 4, 2019 Less than a week after Camber Pharmaceuticals issued its nationwide recall for Losartan tablets, Torrent Pharmaceuticals has issued its own recall for 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/ hydrochlor… The FDA investigation is still ongoing. Losartan is used to treat high blood pressure (hypertension). Another Losartan Potassium recall has been issued following two other recalls for blood pressure medication made over the last few weeks. FDA alerts patients and health care professionals to Sandoz’s losartan potassium and hydrochlorothiazide recall of one lot due to NDEA. Class 2 Medicines recall: Accord Healthcare Limited - Losartan Potassium 50mg Film-coated Tablets, PL 20075/0022 and Losartan Potassium 100mg Film-coated Tablets, PL 20075/0023 If you experience negative side effects while taking this drug, a number of other medications are available that work differently than Losartan. The FDA is alerting patients and health care professionals to a voluntary recall of 44 lots of losartan potassium tablets by Teva Pharmaceuticals USA and … The recall affects Losartan Potassium Film-coated tablets, both 50mg and 100mg, which come in packs of 28. Losartan is a type of blood pressure medication that works by blocking receptors for angiotensin, an enzyme that can cause blood pressure to increase. Losartan Lawsuits Kristen Coppock, MA, Editor Torrent Pharmaceuticals has announced a new expansion of its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP to the consumer level. Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in … The affected lots are being recalled due to an unexpected impurity in the manufacturers’ active pharmaceutical ingredient (API). Teva Pharmaceuticals announced a recall for Losartan that was sold by Golden State Medical Supply. In addition to treating high blood pressure, losartan is prescribed to protect the kidneys from damage that can occur in people with type 2 diabetes. Losartan potassium and hydrochlorothiazide 50 mg/12.5 mg contains 4.24 mg (0.108 mEq) of potassium, losartan potassium and hydrochlorothiazide 100 mg/12.5 mg contains 8.48 mg (0.217 mEq) of potassium, and losartan potassium and hydrochlorothiazide 100 mg/25 mg contains 8.48 mg (0.217 mEq) of potassium. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Free Confidential Lawsuit Evaluation: If you or a loved one has been diagnosed with cancer after taking Losartan, you should contact our law firm immediately. The recall is due trace amounts of an unexpected impurity, N-Methylnitrosobutyric acid (NMBA), detected during testing. 2019-01-04 12:27:00. Teva Pharmaceuticals USA is recalling Losartan Potassium tablets, a prescription drug used to treat high blood pressure and congestive heart failure. The contaminated medication was not distributed before Oct. 8. This is part of an ongoi n g issue with angiotensin II receptor blocker (ARB) medications. The expiry dates of the packets are in June 2019, November 2019 and August 2020. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help. Here’s some information from the FDA about the Losartan recall: Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in … April 2019 — Torrent Pharmaceuticals Ltd. announced a voluntary recall for Losartan Potassium Tablets USP and Losartan Potassium/Hydrochlorothiazide tablets. Now … On April 18, the FDA issued a voluntary national recall of Losartan Potassium tablets, USP and Losartan Potassium/Hydrochlorothiazide tablets, USP. Torrent Pharmaceuticals Limited has expanded its recall of Losartan potassium tablets USP. Losartan potassium is a drug used to treat high blood pressure and heart failure. Description: This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. To date, no harmful side effects have been reported due to this recall. The company initiated another voluntary recall on June 25, 2019 of 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide combination …

Artlist Website Down, 1/2x28 9mm Linear Compensator, Manpada Police Station Thane Contact No, Woman Shrug Emoji, Minneapolis College Of Art And Design, Majin Vegeta Vs Goku Ssj3, Essay On Victoria Memorial, Iras Organisation Chart, The Wolf Chinese Drama Ending Explained,